MECP2 and early-onset autosomal dominant Alzheimer disease: Although the majority of results are associated to neuropsychiatric disorders, our enrichment analysis suggests an interaction between MeCP2 and neurological conditions such as Alzheimer disease, multiple sclerosis and epilepsy.